Sanofi

🇫🇷France

Country: 🇫🇷France

Ownership: Public

Employees: 87.9K

Market Cap: $141.3B

Website: http://www.sanofi.com

Introduction: Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Clinical Trials

Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus

Phase 3

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: insulin glulisine

First Posted Date: 2005-08-25

Last Posted Date: 2011-01-11

Lead Sponsor: Sanofi

Target Recruit Count: 347

Registration Number: NCT00135083

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis

Phase 3

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Teriflunomide
Drug: Placebo (for teriflunomide)

First Posted Date: 2005-08-25

Last Posted Date: 2013-01-04

Lead Sponsor: Sanofi

Target Recruit Count: 1088

Registration Number: NCT00134563

Locations: 🇨🇦
sanofi-aventis, Canada, Laval, Canada
🇸🇪
Sanofi-Aventis, Bromma, Sweden
🇩🇪
Sanofi-Aventis Deutschland GmbH, Berlin, Germany

and more 9 locations

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention

Phase 2

Completed

Conditions: Angioplasty, Transluminal, Percutaneous Coronary

First Posted Date: 2005-08-24

Last Posted Date: 2008-07-02

Lead Sponsor: Sanofi

Target Recruit Count: 947

Registration Number: NCT00133731

Locations: 🇺🇸
Los Angeles Cardiology Associates, Los Angeles, California, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States

and more 86 locations

KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections

Phase 4

Terminated

Conditions: Respiratory Tract Infections
Chronic Bronchitis
Pneumonia

First Posted Date: 2005-08-22

Last Posted Date: 2009-08-27

Lead Sponsor: Sanofi

Target Recruit Count: 2051

Registration Number: NCT00132951

Locations: 🇨🇦
Sanofi-Aventis Administrative Office, Québec, Canada

An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis

Phase 3

Completed

Conditions: Rhinitis, Allergic, Perennial

First Posted Date: 2005-08-22

Last Posted Date: 2011-01-11

Lead Sponsor: Sanofi

Target Recruit Count: 460

Registration Number: NCT00132925

Locations: 🇺🇸
Sanofi-Aventis, Inc., Bridgewater, New Jersey, United States

PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis

Phase 4

Completed

Conditions: Chronic Bronchitis

First Posted Date: 2005-08-22

Last Posted Date: 2011-06-08

Lead Sponsor: Sanofi

Target Recruit Count: 5660

Registration Number: NCT00132938

Locations: 🇹🇷
Sanofi-Aventis, Istanbul, Turkey

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Phase 4

Completed

Conditions: Osteoporosis, Postmenopausal

First Posted Date: 2005-08-15

Last Posted Date: 2011-01-11

Lead Sponsor: Sanofi

Target Recruit Count: 290

Registration Number: NCT00130403

Locations: 🇦🇺
sanofi-aventis, Australia, Cove, New South Wales, Australia
🇨🇦
sanofi-aventis, Canada, Laval, Quebec, Canada
🇧🇪
sanofi-aventis, Belgium, Diegem, Belgium

and more 4 locations

TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis

Phase 4

Completed

Conditions: Osteoarthritis

First Posted Date: 2005-08-15

Last Posted Date: 2008-04-03

Lead Sponsor: Sanofi

Target Recruit Count: 150

Registration Number: NCT00130468

Locations: 🇺🇸
Sanofi-Aventis Inc, Bridgewater, New Jersey, United States

CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer

Phase 4

Terminated

Conditions: Colorectal Cancer

First Posted Date: 2005-08-12

Last Posted Date: 2009-02-13

Lead Sponsor: Sanofi

Target Recruit Count: 180

Registration Number: NCT00129870

Locations: 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States

Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers

Phase 1

Completed

Conditions: Clostridium Infections

Interventions: Biological: Clostridium difficile vaccine
Biological: Placebo (vaccine diluent)

First Posted Date: 2005-08-09

Last Posted Date: 2012-09-14

Lead Sponsor: Sanofi

Target Recruit Count: 50

Registration Number: NCT00127803

Home Terms & Conditions Privacy Policy